IDEXX Laboratories

YTD

ALL

Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About IDXX

IDEXX Laboratories, Inc. engages in the development, manufacturing, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing industries. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other.

CEO

Michael Erickson

CEOMichael Erickson

Employees

11,000

Employees11,000

Headquarters

Westbrook, Maine

HeadquartersWestbrook, Maine

Founded

1983

Founded1983

Employees

11,000

Employees11,000

IDXX Key Statistics

Market cap

48.50B

Market cap48.50B

Price-Earnings ratio

41.78

Price-Earnings ratio41.78

Dividend yield

—

Dividend yield—

Average volume

755.09K

Average volume755.09K

High today

—

High today—

Low today

—

Low today—

Open price

$594.66

Open price$594.66

Volume

0.00

Volume0.00

52 Week high

$769.98

52 Week high$769.98

52 Week low

$518.55

52 Week low$518.55

Stock Snapshot

As of today, IDEXX Laboratories(IDXX) shares are valued at $586.64. The company's market cap stands at 48.5B, with a P/E ratio of 41.78.

During the trading day, IDEXX Laboratories(IDXX) stock saw an opening price of $594.66, a peak of —, and a bottom of —.

Trading volume for IDEXX Laboratories(IDXX) stock has reached 0, versus its average volume of 755.09K.

The stock's 52-week range extends from a low of $518.55 to a high of $769.98.

IDXX News

Simply Wall St 7h

IDEXX Laboratories Unveils First Dual Species Cardiac Test For Dogs And Cats

IDEXX Laboratories (NasdaqGS:IDXX) has launched the Catalyst proBNP Test, the first dual-species point-of-care NT-proBNP cardiac assay for companion animals. T...

MarketWatch 14h

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

...

The Motley Fool 19h

IDEXX Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Mike Erickson Chief Financial Of...

Analyst ratings

53%

of 17 ratings

Buy

52.9%

Hold

41.2%

Sell

5.9%

More IDXX News

TipRanks 24h

Idexx Laboratories announces launch of Catalyst proBNP Test

IDEXX Laboratories (IDXX) announced the launch of the Catalyst proBNP Test, expanding cardiac capabilities across its connected point-of-care and reference labo...

TipRanks 1d

Idexx Laboratories price target lowered to $710 from $800 at Barclays

Barclays analyst Glen Santangelo lowered the firm’s price target on Idexx Laboratories (IDXX) to $710 from $800 and keeps an Overweight rating on the shares. Th...

People also own

Based on the portfolios of people who own IDXX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.